|
|
Article: Eon Labs Receives Approval for Nizatidine Capsules, USP.
- Article from:
- Business Wire
- Article date:
- July 8, 2002
CopyrightCOPYRIGHT 2002 Business Wire. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
Business Editors, Health/Medical Writers
Eon Labs, Inc. (Nasdaq:ELAB) announced today that it received final approval for Nizatidine Capsules, USP the generic alternative for the active duodenal ulcer treatment Axid(R)(a).
Eon Labs approval is for the same strengths as the brand, 150mg and 300mg Capsules. Shipments of Eon Nizatidine are expected to begin shortly. This represents another first to market generic product for Eon Labs.
Eon Labs is a generic pharmaceutical company specializing in developing, licensing, manufacturing, selling and distributing a broad range of prescription pharmaceutical products. Eon's diverse product line includes ...